Scientists test new brain drug on healthy people
NCT ID NCT03771586
Summary
This early-stage study tested an experimental oral drug called SAGE-718 in healthy volunteers. Researchers gave participants SAGE-718 or a placebo, along with a single dose of ketamine, to see how it affected brain wave patterns and to check for safety. The main goal was to gather initial data on how the drug works in the body and brain, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sage Investigational Site
Long Beach, California, 90806, United States
-
Sage Investigational Site
Berlin, New Jersey, 08009, United States
Conditions
Explore the condition pages connected to this study.